-
03:13:48 PM

PFE Stock News

09/22/23 3:16 PM
NYSE : PFE
Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV
Pfizer Inc. shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention’ s Advisory Committee on Immunization Practices following a favorable vote for ABRYSVO™, the company’ s bivalent RSV prefusion F vaccine, as a maternal immunization. The ACIP recommendation follows the U.S. Food...
RHEA-AI
neutral
09/19/23 10:00 AM
NYSE : PFE
conferences
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 2023 Cantor Global Healthcare Conference on Tuesday, September 26, 2023 at 3:30 p.m. EDT. To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on...
RHEA-AI
positive
09/19/23 2:00 AM
NYSE : PFE
European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata
“Today’ s approval of LITFULO in Europe is an important milestone for patients as young as 12 years of age with substantial hair loss from alopecia areata, as they now have an opportunity to achieve significant hair regrowth,” said Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business, Pfizer.“ Previously, there were no treatment...
RHEA-AI
neutral
09/12/23 10:00 AM
NYSE : PFE
conferences
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the J.P. Morgan 14 th Annual U.S. All Stars Conference on Monday, September 18, 2023 at 11:00 a.m. BST. To view and listen to the webcast, visit our web site at www.pfizer.com/investors.
RHEA-AI
positive
09/11/23 1:50 PM
NYSE, Nasdaq : PFE, BNTX
fda approvalcovid-19
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
This season’ s vaccine is tailored to the SARS-CoV-2 XBB.1.5 sublineage and indicated as a single dose for most individuals 5 years of age and older Pre-clinical data show that the updated COVID-19 vaccine generates improved neutralizing antibody responses against multiple circulating Omicron- related sublineages including XBB.1.5, BA.2.86, and EG.5.1,...
RHEA-AI
neutral
09/05/23 10:00 AM
NYSE : PFE
conferences
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business, and Suneet Varma, Global Oncology and U.S. President, at the Morgan Stanley 21 st Annual Global Healthcare Conference on Monday, September 11, 2023 at 12:15 p.m. EDT.
RHEA-AI
positive
08/30/23 10:00 AM
NYSE : PFE
Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
Pfizer Inc. invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences:. Annaliesa Anderson, SVP& Head, Vaccines Research& Development; and Rodrigo Puga, U.S. Commercial and Global Business Lead for Internal Medicine, at the Wells Fargo 2023 Healthcare Conference on Wednesday, September...
RHEA-AI
positive